Literature DB >> 14731216

Electrocardiographic identification of drug-induced QT prolongation: assessment by different recording and measurement methods.

Nenad Sarapa1, Joel Morganroth, Jean-Philippe Couderc, Steven F Francom, Borje Darpo, Joseph C Fleishaker, Janet D McEnroe, William T Chen, Wojciech Zareba, Arthur J Moss.   

Abstract

BACKGROUND: Careful assessment of QT interval prolongation is required before novel drugs are approved by regulatory authorities. The choice of the most appropriate method of electrocardiogram (ECG) acquisition and QT/RR interval measurement in clinical trials requires better understanding of the differences among currently available approaches. This study compared standard and Holter-derived 12-lead ECGs for utility in detecting sotalol-induced QT/QTc and RR changes. Manual methods (digitizing pad and digital on-screen calipers) were compared for precision of QT and RR interval measurement. METHODS AND
RESULTS: Sixteen hundred pairs of serial 12-lead digital ECGs were recorded simultaneously by standard resting ECG device and by continuous 12-lead digital Holter over 3 days in 39 healthy male and female volunteers. No therapy was given on the 1st day followed by 160 mg and 320 mg of sotalol on the 2nd and 3rd day, respectively. Holter-derived and standard ECGs produced nearly identical sotalol-induced QT/QTc and RR changes from baseline, as did the manual digipad and on-screen caliper measurements. The variability of on-screen QT measurement in this study was greater than that of digipad.
CONCLUSIONS: Digital 12-lead Holter and standard 12-lead ECG recorders, as well as the manual digitizing pad and digital on-screen calipers, are of equal utility for the assessment of drug-induced change from baseline in QT and RR interval, although the variability of the on-screen method in this study was greater than of the digipad.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14731216      PMCID: PMC6932311          DOI: 10.1111/j.1542-474x.2004.91546.x

Source DB:  PubMed          Journal:  Ann Noninvasive Electrocardiol        ISSN: 1082-720X            Impact factor:   1.468


  15 in total

Review 1.  Measuring agreement in method comparison studies.

Authors:  J M Bland; D G Altman
Journal:  Stat Methods Med Res       Date:  1999-06       Impact factor: 3.021

Review 2.  The significance of QT interval in drug development.

Authors:  Rashmi R Shah
Journal:  Br J Clin Pharmacol       Date:  2002-08       Impact factor: 4.335

3.  Prediction of sotalol-induced maximum steady-state QTc prolongation from single-dose administration in healthy volunteers.

Authors:  F Le Coz; C Funck-Brentano; J M Poirier; Y Kibleur; F X Mazoit; P Jaillon
Journal:  Clin Pharmacol Ther       Date:  1992-10       Impact factor: 6.875

4.  Assessment of frequency dependency of the class III effects of almokalant: a study using programmed stimulation and recording of monophasic action potentials and ventricular paced QT intervals.

Authors:  B Darpö; O Almgren; R Bergstrand; S Franzén; N Edvardsson
Journal:  Cardiovasc Drugs Ther       Date:  1996-11       Impact factor: 3.727

5.  Relation between QT and RR intervals is highly individual among healthy subjects: implications for heart rate correction of the QT interval.

Authors:  M Malik; P Färbom; V Batchvarov; K Hnatkova; A J Camm
Journal:  Heart       Date:  2002-03       Impact factor: 5.994

Review 6.  Evaluation of drug-induced QT interval prolongation: implications for drug approval and labelling.

Authors:  M Malik; A J Camm
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

7.  Short- and long-term reproducibility of QT, QTc, and QT dispersion measurement in healthy subjects.

Authors:  J Kautzner; G Yi; A J Camm; M Malik
Journal:  Pacing Clin Electrophysiol       Date:  1994-05       Impact factor: 1.976

Review 8.  Arrhythmogenic mechanisms of non-sedating antihistamines.

Authors:  Y G Yap; A J Camm
Journal:  Clin Exp Allergy       Date:  1999-07       Impact factor: 5.018

9.  Human precision of operating a digitizing board: implications for electrocardiogram measurements.

Authors:  M Malik; A Bradford
Journal:  Pacing Clin Electrophysiol       Date:  1998-08       Impact factor: 1.976

10.  Dose-response relation between terfenadine (Seldane) and the QTc interval on the scalar electrocardiogram: distinguishing a drug effect from spontaneous variability.

Authors:  C M Pratt; S Ruberg; J Morganroth; B McNutt; J Woodward; S Harris; J Ruskin; L Moye
Journal:  Am Heart J       Date:  1996-03       Impact factor: 4.749

View more
  24 in total

1.  Comparing methods of measurement for detecting drug-induced changes in the QT interval: implications for thoroughly conducted ECG studies.

Authors:  Nkechi E Azie; Gregory Adams; Borje Darpo; Steven F Francom; Emery C Polasek; Joy M Wisser; Joseph C Fleishaker
Journal:  Ann Noninvasive Electrocardiol       Date:  2004-04       Impact factor: 1.468

2.  Static and Dynamic Electrocardiographic Patterns Preceding Torsades de Pointes in the Acquired and Congenital Long QT Syndrome.

Authors:  Jp Couderc; J Xia; X Xu; S Kaab; M Hinteeser; W Zareba
Journal:  Comput Cardiol (2010)       Date:  2010-09-26

Review 3.  Drugs, QTc interval prolongation and final ICH E14 guideline : an important milestone with challenges ahead.

Authors:  Rashmi R Shah
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

4.  Magnitude, mechanism, and reproducibility of QT interval differences between superimposed global and individual lead ECG complexes.

Authors:  Paul Kligfield; Benoit Tyl; Martine Maarek; Pierre Maison-Blanche
Journal:  Ann Noninvasive Electrocardiol       Date:  2007-04       Impact factor: 1.468

5.  Automated QT analysis that learns from cardiologist annotations.

Authors:  Iain Guy David Strachan; Nicholas Peter Hughes; Mustafa Hashim Poonawala; Jay W Mason; Lionel Tarassenko
Journal:  Ann Noninvasive Electrocardiol       Date:  2009-01       Impact factor: 1.468

6.  Automatic extraction of ECG strips from continuous 12-lead holter recordings for QT analysis at prescheduled versus optimized time points.

Authors:  Fabio Badilini; Martino Vaglio; Nenad Sarapa
Journal:  Ann Noninvasive Electrocardiol       Date:  2009-01       Impact factor: 1.468

7.  Philips QT interval measurement algorithms for diagnostic, ambulatory, and patient monitoring ECG applications.

Authors:  Sophia H Zhou; Eric D Helfenbein; James M Lindauer; Richard E Gregg; Dirk Q Feild
Journal:  Ann Noninvasive Electrocardiol       Date:  2009-01       Impact factor: 1.468

8.  Drug-induced changes in the T-wave morphology.

Authors:  Marek Malik
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

Review 9.  Update on the evaluation of a new drug for effects on cardiac repolarization in humans: issues in early drug development.

Authors:  Vaibhav Salvi; Dilip R Karnad; Gopi Krishna Panicker; Snehal Kothari
Journal:  Br J Pharmacol       Date:  2009-09-23       Impact factor: 8.739

Review 10.  The thorough QT/QTc study 4 years after the implementation of the ICH E14 guidance.

Authors:  Borje Darpo
Journal:  Br J Pharmacol       Date:  2009-11-18       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.